feonie
2 Answers
Colleen
I am not a doctor but my best guess is he's having a reaction to the medication. Call his pediatrician now or take him to the ER.
Complications:
Monoamine oxidase inhibitors: There have been reports of serious, sometimes fatal, reactions (including hyperthermia, rigidity, myoclonus, autonomic instability with possible rapid fluctuations in vital signs and mental status changes that include extreme agitation progressing to delirium and coma.
SIDE-EFFECTS
Body as a whole:
Asthenia, fever, palpitations, visual disturbances.
Digestive system:
Nausea, diarrhoea, dry mouth, appetite loss, dyspepsia, vomiting. Anorexia and loss of mass may also occur.
Nervous system:
Headache, nervousness, insomnia, drowsiness, anxiety, tremor, dizziness, fatigue, decreased libido, seizures (see "Precautions"), abnormal dreams, agitation. Hypomania or mania occurred in approximately 1 % of fluoxetine-treated patients.
Respiratory system:
Dyspnoea. Pulmonary events (including inflammatory processes of varying histopathology and/or fibrosis) have been reported. Dyspnoea may be the only preceding symptom.
Skin and appendages:
A small percentage of patients developed rash and/or urticaria (see "Warnings"). Serious systemic events, possibly related to vasculitis, have developed in patients with rash and less frequently death has been reported. Excessive sweating, serum sickness and anaphylactoid reactions have been reported.
Urogenital system:
Sexual dysfunction (delayed or inhibited orgasm).
Endocrine system:
Hypothyroidism.
Hyponatraemia (including serum sodium lower than 110 mmol/L) has been reported. The hyponatraemia appeared to be reversible when fluoxetine was discontinued. Although these cases were complex with varying possible aetiologies, some were possibly due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH). The majority of these occurrences have been in older patients taking diuretics or who were otherwise volume depleted.
Elevated serum transaminase values have occurred.
Effects on the eyes:
Symptoms of glaucoma developed in a patient receiving fluoxetine, the symptoms subsided within 2 days of drug withdrawal. Intra-ocular pressure following fluoxetine administration was recorded in some patients.
Effects on the hair:
Incidences of hair loss has been reported with fluoxetine.
The following has been reported with fluoxetine, but no causal relationship has been established:
Aplastic anaemia, cerebral vascular accident, confusion, dyskinesia (including, for example, a case of buccallingual-masticatory syndrome, which resolved following drug discontinuation), ecchymoses, eosinophilic pneumonia, gastro-intestinal haemorrhage, hyperprolactinaemia, movement disorders developing in patients with risk factors (including drugs associated with such events) and worsening of pre-existing movement disorders, neuroleptic malignant syndrome-like events, pancreatitis, suicidal ideation, pancytopenia, immune related haemolytic anaemia, thrombocytopenia, thrombocytopenic purpura, vaginal bleeding after withdrawal of the medication and violent behaviour.
| 13 years ago. Rating: 2 | |
feonie
